683 Capital Management, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

683 Capital Management, LLC

$1.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.21 - $0.43 $115,500 - $236,500	-550,000 Reduced 20.75%	2,100,000 $462,000
Q3 2023 Nov 14, 2023	SELL	$0.28 - $0.93 $308,000 - $1.02 Million	-1,100,000 Reduced 29.33%	2,650,000 $795,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $1.26 $110,000 - $252,000	-200,000 Reduced 5.06%	3,750,000 $2.63 Million
Q1 2023 May 15, 2023	BUY	$0.89 - $2.52 $743,150 - $2.1 Million	835,000 Added 26.81%	3,950,000 $3.56 Million
Q4 2022 Feb 14, 2023	SELL	$1.02 - $7.48 $1.24 Million - $9.09 Million	-1,214,751 Reduced 28.06%	3,115,000 $3.68 Million
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $2.81 Million - $4.49 Million	464,751 Added 12.02%	4,329,751 $32.6 Million
Q2 2022 Aug 15, 2022	BUY	$4.99 - $8.96 $2.45 Million - $4.39 Million	490,000 Added 14.52%	3,865,000 $24.4 Million
Q1 2022 May 16, 2022	BUY	$3.84 - $9.74 $288,000 - $730,500	75,000 Added 2.27%	3,375,000 $28 Million
Q4 2021 Feb 14, 2022	BUY	$5.12 - $8.19 $640,000 - $1.02 Million	125,000 Added 3.94%	3,300,000 $17.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $1.5 Million - $2.05 Million	225,000 Added 7.63%	3,175,000 $21.2 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.23 $2.08 Million - $2.46 Million	266,400 Added 9.93%	2,950,000 $25.1 Million
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $484,274 - $745,830	60,686 Added 2.31%	2,683,600 $33 Million
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $3.71 Million - $5.79 Million	466,075 Added 21.61%	2,622,914 $21.4 Million
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $630,930 - $1.56 Million	116,839 Added 5.73%	2,156,839 $20.7 Million
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $932,900 - $2.79 Million	190,000 Added 10.27%	2,040,000 $13.9 Million
Q4 2019 Feb 14, 2020	SELL	$9.77 - $15.66 $102,868 - $164,884	-10,529 Reduced 0.57%	1,850,000 $27.6 Million
Q3 2019 Nov 14, 2019	BUY	$9.59 - $12.0 $239,750 - $300,000	25,000 Added 1.36%	1,860,529 $19.1 Million
Q2 2019 Aug 14, 2019	BUY	$9.54 - $14.96 $2.15 Million - $3.37 Million	225,000 Added 13.97%	1,835,529 $19.5 Million
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $8.45 Million - $12.1 Million	979,296 Added 155.14%	1,610,529 $16.4 Million
Q3 2018 Nov 14, 2018	BUY	$9.6 - $12.9 $3.23 Million - $4.33 Million	335,948 Added 113.77%	631,233 $7.58 Million
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $830,000 - $1.68 Million	100,000 Added 51.21%	295,285 $3.6 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $16.0 $1.58 Million - $3.12 Million	195,285 New	195,285 $1.92 Million

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account